Hypoglycaemia in endocrine, diabetic, and internal diseases [Hipoglikemia w schorzeniach endokrynologicznych, diabetologicznych i internistycznych].
Dominika RokickaBogdan MarekDariusz KajdaniukMarta WróbelAleksandra Szymborska-KajanekMonika Ogrodowczyk-BobikAgata UrbanekSzymon JanygaHalina Borgiel-MarekKrzysztof StrojekPublished in: Endokrynologia Polska (2019)
Hypoglycemia is a decrease in blood glucose concentration below the physiological level. It occurs in healthy people and in people with various diseases with inadequate secretion of insulin by β cells, or deficiency of counterregulatory hormones secreted at the moment of hypoglycemia. Hypoglycemia is also associated with diabetes therapy, regardless of whether behavioral therapy, oral hypoglycemic agents, or insulin are used. Distinguishing the causes of hypoglycemia is the basis for taking appropriate therapeutic actions that protect patients against subsequent episodes of lowering blood glucose and complications caused by hypoglycemia.
Keyphrases
- glycemic control
- blood glucose
- type diabetes
- end stage renal disease
- weight loss
- insulin resistance
- cardiovascular disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- induced apoptosis
- prognostic factors
- stem cells
- metabolic syndrome
- signaling pathway
- patient reported outcomes
- cell therapy
- cell death
- cell proliferation
- bone marrow